New study to test anthrax vaccine in Real-World emergency
NCT ID NCT07268612
First seen Dec 16, 2025 · Last updated May 08, 2026 · Updated 19 times
Summary
This study will check how safe and effective the CYFENDUS anthrax vaccine is when given to people after a large anthrax exposure. Researchers will look at medical records of about 250 people who received the vaccine during a real mass exposure event in the United States. The goal is to see if the vaccine, along with antibiotics, helps prevent serious anthrax disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTHRAX are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.